Autolus Therapeutics plc - Ordinary Shares, nominal value $0.000042 per share, and American Depositary Shares ("ADS"). Each ADS represents one Ordinary Share (AUTL)

48 filings reported holding AUTL - Autolus Therapeutics plc - Ordinary Shares, nominal value $0.000042 per share, and American Depositary Shares ("ADS"). Each ADS represents one Ordinary Share as of Q4 2018.
Autolus Therapeutics plc - Ordinary Shares, nominal value $0.000042 per share, and American Depositary Shares ("ADS"). Each ADS represents one Ordinary Share (AUTL) has 36 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 17M shares of 266M outstanding shares and own 6.38% of the company stock.
Largest 10 shareholders include Woodford Investment Management Ltd (11.9M shares), Polygon Management Ltd. (800K shares), Alphabet Inc. (714K shares), Capital World Investors (611K shares), PRICE T ROWE ASSOCIATES INC /MD/ (502K shares), Capital International Investors (489K shares), Artal Group S.A. (475K shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (236K shares), SPHERA FUNDS MANAGEMENT LTD. (203K shares), and BlackRock Inc. (203K shares).
This table shows the top 36 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.